top of page
FullLogo_Transparent.png
Image by Girl with red hat

Mission + Vision

We bring precision diagnostics and healthcare innovations to market.

Partnering with life science companies and clinical laboratories to translate breakthrough science into clinically adopted solutions that improve patient care and advance modern medicine.

Patient Impact: 

We focus on innovations that meaningfully improve patient outcomes.

Scientific Rigor:

We respect the science and clinical evidence behind precision medicine.

Commercial Excellence:

We combine strategy, market access expertise, and execution to drive real adoption.

Partnership:

We operate as trusted partners, aligned with our clients’ long-term success.

Integrity:

We uphold the highest standards of ethics, transparency, and compliance.

Our Team:

Michael Hellman

  • 27+ years as a passionate and ethical sales leader/sales trainer/salesperson in the Healthcare Industry.

  • Held sale leadership roles with Bristol-Myers Squibb, Kos Pharmaceuticals, DiaDexus, Cleveland Heartlab & Labcorp

  • Multi President's club winner as both director and sales rep in Diagnostics, Bio Tech and Pharmaceuticals

  • Owner of device company that grew business revenues from $200,000 to $3 million in a 3-year period

  • Closed major hospital systems for diagnostics and pharmaceutical formularies (Beaumont, Maryland and UPenn)

  • Expertise in Mental health, Cardio-Metabolic, Oncology, and Women’s Health

Scott Bland

  • 25+ years of healthcare commercialization and leadership in Pharmaceutical, Orthopedic Device, and Lab Diagnostic sales

  • VP of Sales for Berkeley HeartLab (Celera) and Veracyte growing them from a private entity and single digit millions in revenue to $100 million + in sales and successful IPOs

  • Instituted and led multiple corporate commercial partnerships to maximize revenue between KOS and BHL, BHL and Abbott Labs, Veracyte and Genzyme

  • Led the corporate launch of many new and disruptive products in pharmaceuticals, device, and diagnostics such as The Afirma Gene Expression Classifier (thyroid cancer), XLIF (lateral spine), and Berkeley Heartlab Advanced Panel for CVD / CHD

  • CEO of Aegis 6, a Service-Disabled Veteran Owned Small Business specializing in the distribution of medical products and supplies to the VA and DoD

  • US Army Infantry Reserve Officer

Chris Boggess

  • 25+ years of experience driving commercial strategy, product development, and market access across diagnostics and life sciences tools.

  • Served as CEO/Board Member of OligoFactory, where he led a major scale-up to GMP manufacturing, built a high-performing commercial team working with top pharma and life science tools companies, and grew a $30M+ pipeline.

  • Held executive leadership roles at DiscernDx (CBO), seqWell, KEW Group Celera/Berkeley Heartlab delivering transformative results through strategic
    marketing, innovative product launches, and operational excellence.

  • Founder/Partner of Tempus Ventures focused on early-stage venture-backed diagnostics and biotech companies.

  • With a strong technical foundation, Chris combines scientific and clinical depth with proven business acumen to build and grow market-leading ventures.

bottom of page